GGrantIndex
← Leaderboards

Meng Yang

Anticancer, Inc.

$5,001,317
Attributed
$6,708,270
Total exposure
10
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$6,708,270 · 10

By mechanism

R01$3,413,906 · 2
R44$2,250,264 · 3
R43$1,044,100 · 5

Top collaborators

Most similar at Anticancer, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Mouse Model

Research focus

Mouse ModelLabelTumorIn VivoMalignant NeoplasmsFluorescence ImagingCellsAnimalsNeoplasm MetastasisImageColorCancer CellAnimal ModelClinically RelevantMalignant Neoplasm Of PancreasNude MiceImaging TechnologyMonoclonal AntibodiesPancreasLeadAntibodiesCaliforniaCollaborationsPeer Review

Grant awards (28)

Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$79,602
R01 · FY2015 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$300,912
R01 · FY2014 · CA
Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)$224,700
R43 · FY2014 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$111,922
R01 · FY2014 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$291,606
R01 · FY2013 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$278,595
R01 · FY2013 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$310,115
R01 · FY2012 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$296,378
R01 · FY2012 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$25,220
R01 · FY2012 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$309,594
R01 · FY2011 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$296,378
R01 · FY2011 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$47,311
R01 · FY2011 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$319,169
R01 · FY2010 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$305,544
R01 · FY2010 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$22,491
R01 · FY2010 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$319,169
R01 · FY2009 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$99,900
R01 · FY2009 · CA
Dual-color tumor-host imaging models$375,784
R44 · FY2007 · CA · contact PI
Orthotopic models of tumor angiogenesis and blood flow$374,848
R44 · FY2007 · CA · contact PI
Therapeutic hair follicle-derived neurospheres$374,500
R44 · FY2007 · AR · contact PI
Dual-color tumor-host imaging models$375,784
R44 · FY2006 · CA · contact PI
Orthotopic models of tumor angiogenesis and blood flow$374,848
R44 · FY2006 · CA · contact PI
Therapeutic hair follicle-derived neurospheres$374,500
R44 · FY2006 · AR · contact PI
Therapeutic hair follicle-derived neurospheres$149,800
R43 · FY2005 · AR
Dual-color tumor-host imaging models$149,800
R43 · FY2003 · CA
Orthotopic models of tumor angiogenesis and blood flow$149,800
R43 · FY2003 · CA
GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING$120,000
R43 · FY2002 · CA
GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING$250,000
R43 · FY2001 · CA